Home About Cancer News Contact Cancer News
Home About Cancer News Contact Cancer News
Twitter

Archive for May 23rd, 2012

« Older Entries

New Cancer Therapies Likely Following ‘Orphan’ Sleep Drug Findings

By on Wednesday, May 23rd, 2012 | No Comments

An inexpensive “orphan drug” used to treat sleep disorders appears to be a potent inhibitor of cancer cells, according to a new study led by scientists at Fred Hutchinson Cancer Research Center. Their novel approach, using groundbreaking technology that allows rapid analysis of the genome, has broad implications for the development of safer, more-effective cancer therapies…

Read More...

Task force recommends against PSA-based screening for prostate cancer

By on Wednesday, May 23rd, 2012 | No Comments

Following a period for public comment, the United States Preventive Services Task Force (USPSTF) released its final recommendation for prostate cancer screening. The Task Force now recommends against PSA-based screening for all men, regardless of age.

Read More...

Hugo Chavez back on television in Venezuela

By on Wednesday, May 23rd, 2012 | No Comments

Venezuelan President Hugo Chavez reappeared on television Tuesday a week and a half after returning from cancer treatment in Cuba.

Read More...

Greater Hartford: American Cancer Society Program To Help Connecticut Cancer Patients

By on Wednesday, May 23rd, 2012 | No Comments

Representatives from Anthem Blue Cross Blue Shield, the American Cancer Society, Hartford Hospital and UConn Health Center came together for a check presentation at the American Cancer Society office in Rocky Hill .

Read More...

Getting Pain Treatment For ‘Suicide Disease’

By on Wednesday, May 23rd, 2012 | No Comments

It is a pin so severe, it is often called the “suicide disease.” Go inside a treatment that cured a woman of her chronic pain.

Read More...

Mayo Clinic study finds pancreatic cancer may be detected with simple intestinal probe

By on Wednesday, May 23rd, 2012 | No Comments

By simply shining a tiny light within the small intestine, close to that organ’s junction with the pancreas, physicians at Mayo Clinic’s campus in Florida have been able to detect pancreatic cancer 100 percent of the time in a small study. The light, attached to a probe, measures changes in cells and blood vessels in the small intestine produced by a growing cancer in the adjoining pancreas.

Read More...

Fred Hutchinson study finds that moderate weight loss reduces levels of sex hormones linked with increased risk of breast cancer

By on Wednesday, May 23rd, 2012 | No Comments

Even a moderate amount of weight loss can significantly reduce levels of circulating estrogens that are associated with an increased risk of breast cancer, according to a study by researchers at Fred Hutchinson Cancer Research Center – the first randomized, controlled clinical trial to test the effects of weight loss on sex hormones in overweight and obese postmenopausal women, a group at elevated risk for breast cancer.

Read More...

Duke study finds cholesterol-lowering drugs may slow benign prostate growth

By on Wednesday, May 23rd, 2012 | No Comments

Statin drugs prescribed to treat high cholesterol may also work to slow benign prostate growth in men who have elevated PSA levels, according to an analysis led by researchers at Duke University Medical Center. The finding, presented at the annual meeting of the American Urological Association, provides additional insight into the effects statins have on the prostate. Previous studies at Duke and elsewhere had found a link between the cholesterol drugs and lower levels of PSA, a protein produced by the prostate that is often elevated by cancer or by non-lethal prostatic diseases.

Read More...

In Sloan-Kettering study, new drug shows promise for patients with advanced kidney cancer

By on Wednesday, May 23rd, 2012 | No Comments

People with advanced kidney cancer may have a new alternative in their limited arsenal of treatment options that are both well tolerated and effective against the disease. New research led by Memorial Sloan-Kettering has shown that the investigational drug tivozanib is more effective than an approved targeted therapy called sorafenib (Nexavar®) in delaying the growth of their cancer.

Read More...

Adding Vitamin D To BCG Vaccine To Fight Bladder Cancer

By on Wednesday, May 23rd, 2012 | No Comments

The tuberculosis vaccine is often used as a treatment for bladder cancer, and adding vitamin D might improve the vaccine’s effectiveness, according to new research from the University of Rochester Medical Center presented today at the American Urological Association annual meeting. Yi-Fen Lee, Ph.D…

Read More...
« Older Entries